Joshua A. Bloomstone, MD
Washington—Intraoperative goal-directed fluid therapy has been an essential component of enhanced recovery after surgery (ERAS) protocols, but findings from a recent quality improvement initiative questioned its clinical value and impact.
In the presence of an ERAS pathway that included early ambulation and alimentation, the addition of intraoperative goal-directed fluid therapy did not reduce complications, readmissions or cost in patients undergoing elective